Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy

Cytotherapy

Volumn 10, Issue 8, 2008, Pages 857-867

  Guo, Ying Hua ^d   He, Jian Guo ^a   Wu, Jun Lou ^b   Yang, Long ^c   Zhang, Dong Sheng ^b   Tan, Siao Yan ^a   Qi, Rui Dong ^a  

^a FUWAI HOSPITAL   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cell transplantation; Granulocyte colony stimulating factor; Hepatocyte growth factor; Myocardial infarction

Indexed keywords

ADENOVIRUS VECTOR; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; SCATTER FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL DENSITY; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DNA MODIFICATION; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HEART DILATATION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE RELAXATION; HEART MUSCLE ISCHEMIA; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; RAT; STROMA CELL;

EID: 57949092672     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802419278     Document Type: Article

References (29)

1. American Heart Association (2002) American Heart Association, Dallas
2. Pfeffer, MA and Braunwald, E. (1990) Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation, 81, pp. 1161-1172.
3. Malekan, R., Reynolds, C. Narula, N. et al. (1998) Angiogenesis in transmyocardial laser revascularization: A nonspecific response to injury. Circulation, 98, pp. 1162-1166.
4. Heuser, R., Houser, F. Culler, SD et al. (2000) A retrospective study of 6,671 patients comparing coronary stenting and balloon angioplasty. J Invasive Cardiol, 12, pp. 354-362.
5. Karolak, W., Hirsch, G. Buth, K. et al. (2007) Medium-term outcomes of coronary artery bypass graft surgery on pump versus off pump: Results from a randomized controlled trial. Am Heart J, 153, pp. 689-695.
6. Salam, AM. (2003) Selective aldosterone blockade with eplerenone in patients with congestive heart failure. Expert Opin Invest Drugs, 12, pp. 1423-1427.
7. Orlic, D., Kajstura, J. Chimenti, S. et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature, 410, pp. 701-705.
8. Etzion, S., Battler, A. Barbash, IM et al. (2001) Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol, 33, pp. 1321-1330.
9. Bonaros, N., Rauf, R. Wolf, D. et al. (2006) Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure. J Thorac Cardiovasc Surg, 132, pp. 1321-1328.
10. Losordo, DW, Vale, PR Symes, JF et al. (1998) Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation, 98, pp. 2800-2804.
11. Korpanty, G., Chen, S. Shohet, RV et al. (2005) Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther, 12, pp. 1305-1312.
12. Walter, DH, Rittig, K. Bahlmann, FH et al. (2002) Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow derived endothelial progenitor cells. Circulation, 105, pp. 3017-3024.
13. Weimar, IS, Miranda, N. Muller, EJ et al. (1998) Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp Hematol, 26, pp. 885-894.
14. Jayasankar, V., Woo, J. Bish, LT et al. (2003) Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation, 108, pp. 11230-11236.
15. Pittenger, MF, Mackay, AM Beck, SC et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, pp. 143-147.
16. Conget, PA and Minguell, JJ. (1999) Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol, 181, pp. 67-73.
17. Zhang, YR, Wu, DL Lao, MF et al. (2003) The comparative efficacy of recombinant adenovirus and plasmid in treatment of myocardial ischemia. Bull Acad Military Med Sci, 27, pp. 16-18.
18. Duan, HF, Wu, CT Wu, DL et al. (2003) Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther, 8, pp. 467-474.
19. Vandervelde, S., van Luyn, MJ Tio, RA et al. (2005) Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol, 39, pp. 363-376.
20. Askari, AT, Unzek, S. Popovic, ZB et al. (2003) Effect of stromal cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet, 362, pp. 697-703.
21. Ieda, Y., Fujita, J. Ieda, M. et al. (2007) G-CSF and HGF: Combination of vasculogenesis and angiogenesis synergistically improves recovery in murine hind limb ischemia. J Mol Cell Cardiol, 42, pp. 540-548.
22. Jayasankar, V., Woo, J. Bish, LT et al. (2003) Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation, 108, pp. 11230-11236.
23. Shao, ZQ, Takaji, K. Katayama, Y. et al. (2006) Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model. Circ J, 70, pp. 471-477.
24. Shujia, J., Haider, HK Idris, NM et al. (2008) Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair. Cardiovasc Res, 77, pp. 525-533.
25. Woo, YJ, Grand, TJ Berry, MF et al. (2005) Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. J Thorac Cardiovasc Surg, 130, pp. 321-329.
26. Van den Steen, PE, Dubois, B. Nelissen, I. et al. (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol, 37, pp. 375-536.
27. Bergers, G., Brekken, R. McMahon, G. et al. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol, 2, pp. 737-744.
28. Schnaper, HW, Grant, DS Stetler-Stevenson, WG et al. (1993) Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol, 156, pp. 235-246.
29. Jodele, S., Chantrain, CF Blavier, L. et al. (2005) The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res, 65, pp. 3200-3208.